Trump announced the introduction of a 100% duty on a number of imported medicines.

The United States will impose 100% duties on a number of medicines for companies that have not concluded an agreement with Washington. This was announced on April 2 by US President Donald Trump, the document was published on the White House website.

"I have determined that it is necessary and appropriate to impose a 100% ad valorem duty on imports of patented pharmaceutical products and related pharmaceutical ingredients," the document says.

It is specified that the duties will apply only to products of companies that have not agreed to lower drug prices or move production to the United States.

The news is being updated